🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to compare safety and efficacy of a single dose...
Status
Completed
Location
Arkhangelsk District Clinical Oncology Dispensary
Start Date
2013-09
Trial ID
NCT02104830
Treatments Being Tested
Targeted therapy in the treatment of breast cancer targets HER2 receptor (H...
Status
Completed
Location
19-8 Hospital
Start Date
2018-02-02
Trial ID
NCT05301010
The primary objective of this clinical study is to compare the pharmacokine...
Status
Completed
Location
Regional State Budgetary Healthcare Institution "Altai Regional Oncological Dispensary"
Start Date
2020-06-15
Trial ID
NCT07435311
Primary Objective: * To demonstrate the superiority of cabazitaxel plus pr...
Status
Completed
Location
Investigational Site Number 840004
Start Date
2011-05-05
Trial ID
NCT01308567
Treatments Being Tested
Based on the unmet clinical need to reduce invasiveness of treatment of low...
Status
Not Yet Recruiting
Location
Roland Seiler
Start Date
2024-10
Trial ID
NCT06227065
Treatments Being Tested
This study evaluates the use of NanoDoce injected directly into tumors in t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-04
Trial ID
NCT04260360
Treatments Being Tested
This is a research study which aims to improve the way that doctors determi...
Status
Completed
Location
University of Michigan Cancer Center
Start Date
1999-03
Trial ID
NCT00148070
Treatments Being Tested
The purpose of the study is to compare safety and efficacy of a single dose...
Status
Completed
Location
Arkhangelsk District Clinical Oncology Dispensary
Start Date
2012-05
Trial ID
NCT01569087
Treatments Being Tested
This is a Phase 1, open-label, multicenter study of continuous oral dosing ...
Status
Completed
Location
Research Site
Start Date
2016-06-17
Trial ID
NCT02740985
Treatments Being Tested
This phase Ib/II trial compares the safety, tolerability and acceptability ...
Status
Recruiting
Location
Mayo Clinic in Florida
Start Date
2025-04-21
Trial ID
NCT06704191